Skip to main navigation
Skip to search
Skip to main content
University Medical Center Utrecht Home
Help & FAQ
Home
Profiles
Research units
Research output
Activities
Prizes
Press/Media
Search by expertise, name or affiliation
Management of hyperuricemia with rasburicase review
JM de Bont, R Pieters
*
*
Corresponding author for this work
Research output
:
Contribution to journal
›
Article
›
Academic
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Management of hyperuricemia with rasburicase review'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
rasburicase
100%
Hyperuricemia
71%
Uric Acid
58%
Urate Oxidase
53%
Allantoin
36%
Allopurinol
29%
monobasic calcium phosphate
20%
Tumor Lysis Syndrome
17%
Hyperphosphatemia
15%
Xanthine
14%
Hypoxanthine
14%
Hyperkalemia
14%
Xanthine Oxidase
14%
Hypocalcemia
13%
Hematologic Neoplasms
11%
Renal Insufficiency
10%
Salts
10%
Hypersensitivity
9%
Clinical Trials
7%
Costs and Cost Analysis
7%
Enzymes
6%
Kidney
6%
Incidence
5%
Therapeutics
3%
Neoplasms
3%
Chemistry
Uric Acid
62%
Allantoin
35%
Allopurinol
33%
Xanthine
25%
Phosphate Salt
16%
Haematological
16%
Hypoxanthine
14%
Calcium Phosphate
12%
Metabolic
9%
Block Like Crystal
7%
Time
4%